IFNB1 and COVID-19: However, researchers have also proven that IFN-β does not show significant efficacy in the treatment of COVID-19 (55, 56), indicating that SARS-CoV-2 not only inhibits the production of IFN-I but also inhibits the IFN-I response, and the mechanism underlying inhibition of IFN-I still needs to be studied.